Rhythm Pharmaceuticals (RYTM)
(Real Time Quote from BATS)
$39.98 USD
+1.51 (3.93%)
Updated Apr 23, 2024 09:54 AM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/7/24 |
---|---|
Current Quarter | -2.12 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | 0.00% |
ABR | 1.11 |
Earnings ESP
|
-13.61% |
---|---|
Current Year | -4.05 |
Next Year | -1.97 |
EPS (TTM) | -3.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 27.53M | 31.50M | 133.20M | 197.45M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 31.50M | 34.50M | 142.00M | 225.00M |
Low Estimate | 25.80M | 28.00M | 115.61M | 164.72M |
Year ago Sales | 11.47M | 19.22M | 77.43M | 133.20M |
Year over Year Growth Est. | 140.03% | 63.91% | 72.03% | 48.23% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.12 | -0.64 | -4.05 | -1.97 |
# of Estimates | 8 | 7 | 8 | 8 |
Most Recent Consensus | -2.34 | -0.62 | -3.88 | -1.53 |
High Estimate | -0.59 | -0.59 | -2.19 | -0.79 |
Low Estimate | -2.41 | -0.72 | -4.95 | -3.84 |
Year ago EPS | -0.92 | -0.82 | -3.20 | -4.05 |
Year over Year Growth Est. | -130.43% | 21.95% | -26.56% | 51.48% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 3 | 2 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.12 | -0.64 | -4.05 | -1.97 |
7 Days Ago | -2.12 | -0.64 | -4.05 | -1.97 |
30 Days Ago | -2.12 | -0.64 | -4.03 | -1.95 |
60 Days Ago | -1.35 | -0.59 | -2.97 | -1.44 |
90 Days Ago | -0.70 | -0.59 | -2.35 | -0.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.41 | -0.64 | -4.41 | -0.79 |
Zacks Consensus Estimate | -2.12 | -0.64 | -4.05 | -1.97 |
Earnings ESP | -13.61% | 0.00% | -8.89% | 59.80% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | -0.76 | -0.82 | -0.92 | NA |
Estimate | -0.70 | -0.76 | -0.80 | -0.71 | NA |
Difference | 0.00 | 0.00 | -0.02 | -0.21 | -0.06 |
Surprise | 0.00% | 0.00% | -2.50% | -29.58% | -8.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more